hemophilianewstoday10d
Preventive treatment with Altuviiio better than Hemlibra: Analysis
Preventive treatment with Altuviiio led to lower bleed rates and better joint health than Hemlibra in hemophilia A patients ...
The American Journal of Managed Care3d
First Subcutaneous Prophylaxis for Hemophilia A and B With Inhibitors Approved by FDA
The approval of concizumab-mtci (Alhemo) injection marks a significant milestone in managing hemophilia A and B with ...
ViewusGlobal on MSN16h
FDA Apporoves ‘Alhemo’ to Help Hemophilia Patients Manage Bleeding
Novo Nordisk’s hemophilia treatment has received approval from the U.S. Food and Drug Administration (FDA). The FDA has ...
Nebraska Medicine administers novel gene therapy to first hemophilia patient
Chad Stevens traveled from Idaho to Omaha's Nebraska Medical Center, where he became the hospital's first patient to receive ...
Managed Healthcare Executive3d
Alhemo Once-Daily Treatment for Hemophilia A, B with Inhibitors FDA Approved
The FDA recently approved the treatment by Novo Nordisk for hemophilia A or B with inhibitors, designed to prevent or reduce ...
hemophilianewstoday7d
Altuviiio bests others as hemophilia A factor replacement therapy
Altuviiio (efanesoctocog alfa) may work better than other treatments as a hemophilia A factor replacement therapy, a study ...
Novo Nordisk bleeding prevention injection for hemophilia granted FDA nod
Novo Nordisk (NVO) announced that the U.S. Food and Drug Administration (FDA) has approved its Alhemo (concizumab-mtci) ...